Lonza gains SafeBridge certification at ADC facilities
Lonza, the Swiss chemicals and biotechnology company, has become the first continental European contract manufacturer to be awarded Potent Compound Safety Certification approval by Californian firm SafeBridge Consultants.
Lonza, the Swiss chemicals and biotechnology company, has become the first continental European contract manufacturer to be awarded Potent Compound Safety Certification approval by Californian firm SafeBridge Consultants.
Lonza’s antibody drug conjugate (ADC) manufacturing and process development facilities, operations and associated quality control laboratories in Basel received certification after rigorous tests.
The SafeBridge Potent Compound Safety Certification programme verifies performance with established criteria in management, evaluation, containment, control, and communication elements of potent compound production operations. The programme includes on-site assessment of the manufacturing and laboratory areas and equipment, training, toxicology and industrial hygiene.
Since the inception of the SafeBridge programme in 1999, six organisations have achieved certification.
